Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on inflammatory markers study: A substudy of achieve cholesterol targets fast with atorvastatin stratified titration

Blanco-Colio, L. et al. (2007) Elevated ICAM-1 and MCP-1 plasma levels in subjects at high cardiovascular risk are diminished by atorvastatin treatment. Atorvastatin on inflammatory markers study: A substudy of achieve cholesterol targets fast with atorvastatin stratified titration. American Heart Journal, 153, pp. 881-888. (doi:10.1016/j.ahj.2007.02.029)

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Gaw, Dr Allan
Authors: Blanco-Colio, L., Martin-Ventura, J., de Teresa, E., Farsang, C., Gaw, A., Gensini, G., Leiter, L., Langer, A., Martineau, P., Egido, J., and ACTFAST investigators,
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
College of Medical Veterinary and Life Sciences
Journal Name:American Heart Journal

University Staff: Request a correction | Enlighten Editors: Update this record